Surrozen's top three insider shareholders as of April 17, 2026 are Tim Kutzkey (Director, 1.92Mn shares), Group Iii Gp, Lp Column (TenPercentOwner, 1.92Mn shares), Kevin Harold Livingston (Other, 1.89Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Group Iii Gp, Lp Column | - | 0 | 1,916,950 | 20 Jan, 2026 |
| Tim Kutzkey | - | 0 | 1,916,950 | 20 Jan, 2026 |
| Life Sciences Consonance | - | 0 | 1,885,000 | 13 Aug, 2021 |
| Kevin Harold Livingston | - | 0 | 1,885,000 | 13 Aug, 2021 |
| Benny Soffer | - | 0 | 1,885,000 | 13 Aug, 2021 |
| Crossover Gp Ii, Llc Tcg | - | 0 | 736,547 | 25 Mar, 2026 |
| Group Iii Gp, Lp Column | - | 0 | 344,827 | 28 Mar, 2025 |
| Geertrui Vanhove | Chief Medical Officer | 32,412 | 0 | 19 Dec, 2022 |
| Donald J Santel | - | 30,000 | 0 | 13 Aug, 2021 |
| Jennifer Jarrett | - | 30,000 | 0 | 13 Aug, 2021 |
| Christopher Haqq | - | 30,000 | 0 | 13 Aug, 2021 |
| Wen-Chen Yeh | Chief Scientific Officer | 27,216 | 0 | 19 Jun, 2023 |
| Yang Li | Exec. Vice President, Research | 14,425 | 0 | 01 Apr, 2026 |
| Charles O Williams | Chief Operating Officer | 12,982 | 0 | 06 Jan, 2026 |
| Craig C Parker | Chief Executive Officer | 8,577 | 0 | 16 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Mar, 2026 | Yang Li | Common Stock | D | 1,666 | $0.00 | 14,425 | D | G |
| 23 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 7,612 | $24.90 | 683,225 | I | P |
| 23 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 7,611 | $24.90 | 683,218 | I | P |
| 24 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 53,329 | $24.69 | 736,554 | I | P |
| 24 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 53,329 | $24.69 | 736,547 | I | P |
| 12 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 6,187 | $24.99 | 657,301 | I | P |
| 12 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 6,187 | $24.99 | 657,299 | I | P |
| 13 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 17,717 | $24.88 | 675,018 | I | P |
| 13 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 17,716 | $24.88 | 675,015 | I | P |
| 16 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 595 | $24.99 | 675,613 | I | P |
| 16 Mar, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 595 | $24.99 | 675,610 | I | P |
| 17 Feb, 2026 | Charles O Williams | Employee Stock Option (right to buy) | A | 102,900 | $0.00 | 102,900 | D | A |
| 17 Feb, 2026 | Craig C Parker | Employee Stock Option (right to buy) | A | 242,200 | $0.00 | 242,200 | D | A |
| 17 Feb, 2026 | Yang Li | Employee Stock Option (right to buy) | A | 100,950 | $0.00 | 100,950 | D | A |
| 17 Feb, 2026 | Craig C Parker | Restricted Stock Unit | A | 242,200 | $0.00 | 242,200 | D | A |
| 17 Feb, 2026 | Yang Li | Restricted Stock Unit | A | 100,950 | $0.00 | 100,950 | D | A |
| 17 Feb, 2026 | Charles O Williams | Restricted Stock Unit | A | 102,900 | $0.00 | 102,900 | D | A |
| 11 Feb, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 8,882 | $23.58 | 650,567 | I | P |
| 11 Feb, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 8,881 | $23.58 | 650,563 | I | P |
| 12 Feb, 2026 | Crossover Gp Ii, Llc Tcg | Common Stock | A | 547 | $23.86 | 651,114 | I | P |